DIALYSIS · CCN 212681

USRC BETHESDA DIALYSIS

BETHESDA, MD 20816

DialysisProfitUS Renal Care, Inc.
$4.0M
TOTAL REVENUE
7.6%
OPERATING MARGIN
5 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.0M
Total costs
$3.7M
Operating income (rev − costs)
$303K
Operating margin
7.6%
Total charges
$4.0M
Total treatments
8,663
Dialysis stations
9

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
10045—
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9224—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.9745—
Fistula Rate
DFC_FISTULA_RATE
52.147—
Five Star Rating
DFC_FIVE_STAR
5——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
13449—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
168—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
847—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
23.2201—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
41.643—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
14.934—
Standardized ED Visits Ratio
DFC_SEDR
0.9540—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
12.233—